| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.026 | 0.8 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |